Holder evidence
37
SEC ownership of Keenova Therapeutics plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001567892.
Lead holder
GOLDENTREE ASSET MANAGEMENT LP
13D/G signal
GOLDENTREE ASSET MANAGEMENT LP
Latest evidence
19 May 2026
- SEC evidence mix
- 3/4/5 and 13D/G
- Lead holder
- GOLDENTREE ASSET MANAGEMENT LP
- Latest large-stake holder
- GOLDENTREE ASSET MANAGEMENT LP
- Latest evidence date
- 19 May 2026
- CIK
- 0001567892
- Location
- Dublin 15
Ownership snapshot
4 facts
Issuer identity
2 facts
Ownership snapshot
Top shareholders of Keenova Therapeutics plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
GOLDENTREE ASSET MANAGEME...
13D/G signal
GOLDENTREE ASSET MANAGEME...
Evidence rows
37
Latest as of
19 May 2026
3/4/5
13D/G
Lead comparable stake: 20%
13D/G row: GOLDENTREE ASSET MANAGEMENT LP
Showing 1-8 of 37 holder rows.
Rank 1 holder
GOLDENTREE ASSET MANAGEMENT LP
3/4/5
13D/G
- Ownership
- 20%
- Position
- $736.14M
Rank 2 holder
Silver Point Capital L.P.
3/4/5
13D/G
- Ownership
- 15%
- Position
- $456.89M
Rank 3 holder
MARATHON ASSET MANAGEMENT LP
13D/G
- Ownership
- 6.8%
- Position
- —
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GOLDENTREE ASSET MANAGEMENT LP |
3/4/5
13D/G
10%+ Owner · Steven A. Tananbaum
|
20%
from 13D/G
|
$736,139,041
7,979,827 shares
|
+$7,562,250 | 04 Aug 2025 |
| Silver Point Capital L.P. |
3/4/5
13D/G
10%+ Owner
|
15%
from 13D/G
|
$456,887,866
6,035,214 shares
|
+$67,917,443 | 19 May 2026 |
| MARATHON ASSET MANAGEMENT LP |
13D/G
MARATHON ASSET MANAGEMENT GP, L.L.C.
|
6.8%
|
—
2,710,229 shares
|
$0 | 31 Mar 2026 |
| Hein Park Capital Management LP |
13D/G
|
5.5%
|
—
2,146,733 shares
|
$0 | 31 Dec 2025 |
| Hudson Bay Capital Management LP |
13D/G
|
5.2%
|
—
2,049,739 shares
|
$0 | 31 Dec 2025 |
| James E. Flynn |
13D/G
Deerfield Management Company, L.P.
|
4.1%
|
—
804,259 shares
|
$0 | 31 Mar 2025 |
| Edward A. Mule |
3/4/5
10%+ Owner
|
15%
|
$520,079,117
6,035,214 shares
|
— | 19 May 2026 |
| Robert J. O'Shea |
3/4/5
10%+ Owner
|
15%
|
$520,079,117
6,035,214 shares
|
— | 19 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$75,479,692.
Buys
$75,479,692
Insiders: 2
Sells
$0
Insiders: 0
Net
+$75,479,692
Shares: +825,674
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 825,674
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 380,974 | 0 | $34,686,442 | $0 | +$34,686,442 |
| 6-9 | 358,000 | 0 | $33,231,000 | $0 | +$33,231,000 |
| 9-12 | 86,700 | 0 | $7,562,250 | $0 | +$7,562,250 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 55 reporting-owner rows connected to Keenova Therapeutics plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
55
Lead holder
GOLDENTREE ASSET MANAGEMENT LP
Net 12M change
+$75,479,693
Latest report
19 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| GOLDENTREE ASSET MANAGEMENT LP | 10%+ Owner | $736,139,041 | +$7,562,250 | +1% | Mixed | 04 Aug 2025 |
| Robert J. O'Shea | 10%+ Owner | $520,079,117 | Mixed | 19 May 2026 | ||
| Edward A. Mule | 10%+ Owner | $520,079,117 | Mixed | 19 May 2026 | ||
| Silver Point Capital L.P. | 10%+ Owner | $456,887,866 | +$67,917,443 | +17% | Mixed | 19 May 2026 |
| Alta Fundamental Advisers LLC | 10%+ Owner | $73,015,988 | Mixed | 16 Jun 2023 | ||
| Olafsson Sigurdur O | President and CEO, Director | $2,814,973 | Mixed | 25 Feb 2026 | ||
| Christiana Stamoulis | President and CFO | $1,582,235 | Mixed | 25 Feb 2026 | ||
| David J. Stetson | Director | $1,001,497 | Mixed | 31 Jul 2025 | ||
| Wesley Wheeler | Director | $869,585 | Mixed | 31 Jul 2025 | ||
| Abbas Hussain | Director | $846,230 | Mixed | 31 Jul 2025 | ||
| Paul Efron | Director | $781,319 | Mixed | 23 Feb 2026 | ||
| Lisa French | EVP & Chief Commercial Officer | $744,613 | Mixed | 25 Feb 2026 | ||
| Mark Anthony Tyndall | EVP & CLO and Corp Sec | $724,821 | Mixed | 25 Feb 2026 | ||
| Jon Zinman | Director | $712,751 | Mixed | 23 Feb 2026 | ||
| Henriette Nielsen | EVP & Chief Transformation OFC | $668,998 | Mixed | 25 Feb 2026 | ||
| Bradley Mark T. | EVP, Chief Integration Officer | $371,431 | Mixed | 31 Jul 2025 | ||
| Paul Bisaro | Director | $370,798 | Mixed | 23 Feb 2026 | ||
| Katina Dorton | Director | $222,319 | Mixed | 23 Feb 2026 | ||
| Hugh Paul ONeill | EVP, Chief Operations Officer | $159,928 | Mixed | 25 Feb 2026 | ||
| Sophia D. Langlois | Director | $68,768 | Mixed | 23 Feb 2026 |
Recent insider transactions for Keenova Therapeutics plc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Silver Point Capital L.P. | Common Stock | Purchase | 3.61% | 210,000 | 6,035,214 | 20 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.61% | 210,000 | 6,035,214 | 20 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.61% | 210,000 | 6,035,214 | 20 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.33% | 187,500 | 5,825,214 | 19 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.33% | 187,500 | 5,825,214 | 19 May 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 3.33% | 187,500 | 5,825,214 | 19 May 2026 | Direct | |||
| Tracy Basso | Ordinary Shares | Options Exercise | 194.8% | 1,523 | 2,305 | 23 Apr 2026 | Direct | |||
| Tracy Basso | Restricted Stock Units | Options Exercise | -3.16% | -1,523 | 46,717 | 23 Apr 2026 | Direct | |||
| Cheryl Ann Stouch | Ordinary Shares | Options Exercise | 180.2% | 1,137 | 1,768 | 23 Apr 2026 | Direct | |||
| Cheryl Ann Stouch | Restricted Stock Units | Options Exercise | -4.34% | -1,137 | 25,032 | 23 Apr 2026 | Direct | |||
| Susan Ann Williamson | Ordinary Shares | Options Exercise | 179.8% | 1,305 | 2,031 | 23 Apr 2026 | Direct | |||
| Susan Ann Williamson | Restricted Stock Units | Options Exercise | -4.71% | -1,305 | 26,378 | 23 Apr 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 7.84% | 410,000 | 5,637,714 | 17 Apr 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 7.84% | 410,000 | 5,637,714 | 17 Apr 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 7.84% | 410,000 | 5,637,714 | 17 Apr 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 5.55% | 275,000 | 5,227,714 | 15 Apr 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 5.55% | 275,000 | 5,227,714 | 15 Apr 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 5.55% | 275,000 | 5,227,714 | 15 Apr 2026 | Direct | |||
| Henriette Nielsen | Restricted Stock Units | Award | 112.5% | 51,794 | 97,825 | 25 Feb 2026 | Direct | |||
| Marek Honczarenko | Restricted Stock Units | Award | 58,434 | 58,434 | 25 Feb 2026 | Direct | ||||
| Lisa French | Restricted Stock Units | Award | 112.5% | 51,794 | 97,825 | 25 Feb 2026 | Direct | |||
| Tracy Basso | Restricted Stock Units | Award | 251.8% | 34,528 | 48,240 | 25 Feb 2026 | Direct | |||
| Susan Ann Williamson | Restricted Stock Units | Award | 135.7% | 15,936 | 27,683 | 25 Feb 2026 | Direct | |||
| Mark Anthony Tyndall | Restricted Stock Units | Award | 112.5% | 51,794 | 97,825 | 25 Feb 2026 | Direct | |||
| Cheryl Ann Stouch | Restricted Stock Units | Award | 155.7% | 15,936 | 26,169 | 25 Feb 2026 | Direct | |||
| Christiana Stamoulis | Restricted Stock Units | Award | 138.9% | 101,262 | 174,181 | 25 Feb 2026 | Direct | |||
| Hugh Paul ONeill | Restricted Stock Units | Award | 240% | 34,528 | 48,913 | 25 Feb 2026 | Direct | |||
| Olafsson Sigurdur O | Restricted Stock Units | Award | 64.4% | 198,539 | 506,815 | 25 Feb 2026 | Direct | |||
| Jon Zinman | Restricted Stock Units | Award | 11.2% | 3,984 | 39,554 | 23 Feb 2026 | Direct | |||
| Marc J. Yoskowitz | Restricted Stock Units | Award | 81.6% | 5,312 | 11,821 | 23 Feb 2026 | Direct | |||
| Sophia D. Langlois | Restricted Stock Units | Award | 81.6% | 3,984 | 8,866 | 23 Feb 2026 | Direct | |||
| Scott Hirsch | Restricted Stock Units | Award | 81.6% | 3,984 | 8,866 | 23 Feb 2026 | Direct | |||
| Paul Efron | Restricted Stock Units | Award | 61.2% | 3,984 | 10,494 | 23 Feb 2026 | Direct | |||
| Katina Dorton | Restricted Stock Units | Award | 14.3% | 3,984 | 31,882 | 23 Feb 2026 | Direct | |||
| Leslie E. Donato | Restricted Stock Units | Award | 81.6% | 3,984 | 8,866 | 23 Feb 2026 | Direct | |||
| Paul Bisaro | Restricted Stock Units | Award | 9.21% | 3,984 | 47,225 | 23 Feb 2026 | Direct | |||
| Silver Point Capital L.P. | Common Stock | Purchase | 5.32% | $23,062,500 | $92.25 | 250,000 | 4,952,714 | 07 Jan 2026 | Direct | |
| Jon Zinman | Ordinary Shares | Options Exercise | 120.2% | 4,384 | 8,031 | 01 Jan 2026 | By JZ Advisors LLC | |||
| Jon Zinman | Restricted Stock Units | Options Exercise | -11% | -4,384 | 35,570 | 01 Jan 2026 | Direct | |||
| Mark Anthony Tyndall | Ordinary Shares | Tax liability | -20.5% | -2,107 | 8,167 | 01 Jan 2026 | Direct | |||
| Mark Anthony Tyndall | Ordinary Shares | Options Exercise | 177.8% | 6,576 | 10,274 | 01 Jan 2026 | Direct | |||
| Mark Anthony Tyndall | Restricted Stock Units | Options Exercise | -12.5% | -6,576 | 46,031 | 01 Jan 2026 | Direct | |||
| Hugh Paul ONeill | Ordinary Shares | Tax liability | -37.3% | -1,073 | 1,802 | 01 Jan 2026 | Direct | |||
| Hugh Paul ONeill | Ordinary Shares | Options Exercise | 250.6% | 2,055 | 2,875 | 01 Jan 2026 | Direct | |||
| Hugh Paul ONeill | Restricted Stock Units | Options Exercise | -12.5% | -2,055 | 14,385 | 01 Jan 2026 | Direct | |||
| Olafsson Sigurdur O | Ordinary Shares | Tax liability | -34.8% | -16,939 | 31,718 | 01 Jan 2026 | Direct | |||
| Olafsson Sigurdur O | Ordinary Shares | Options Exercise | 208.4% | 32,878 | 48,657 | 01 Jan 2026 | Direct | |||
| Olafsson Sigurdur O | Restricted Stock Units | Options Exercise | -9.64% | -32,878 | 308,276 | 01 Jan 2026 | Direct | |||
| Henriette Nielsen | Ordinary Shares | Tax liability | -24.1% | -2,398 | 7,538 | 01 Jan 2026 | Direct | |||
| Henriette Nielsen | Ordinary Shares | Options Exercise | 195.7% | 6,576 | 9,936 | 01 Jan 2026 | Direct |
* indicates a reported price that failed the local validity check.